Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.201
-0.003 (-1.42%)
Apr 29, 2026, 1:51 PM EDT - Market open
Liminatus Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 9 | 17 | 80 | 75 | 349 | 337 |
| Market Cap Growth | -89.10% | -79.39% | 6.12% | -78.38% | 3.48% | - |
| Enterprise Value | 10 | 17 | 97 | 89 | - | - |
| Last Close Price | 0.20 | 0.61 | 11.22 | 10.33 | 10.12 | 9.78 |
| PB Ratio | - | -1.68 | -4.14 | -4.78 | -32.30 | -29.64 |
| Debt / Equity Ratio | -0.15 | -0.15 | -1.03 | -1.02 | -1.53 | -1.16 |
| Net Debt / Equity Ratio | -0.11 | -0.11 | -1.03 | -0.99 | -1.06 | -1.16 |
| Net Debt / EBITDA Ratio | -0.37 | -0.37 | - | - | -4.23 | -3.30 |
| Net Debt / FCF Ratio | -0.11 | -0.11 | -13.73 | -4.67 | -13.18 | -78.47 |
| Quick Ratio | 0.03 | 0.03 | 0.00 | 0.03 | 0.29 | 0.00 |
| Current Ratio | 0.05 | 0.05 | 0.21 | 0.12 | 0.39 | 0.19 |
| Return on Assets (ROA) | -62.65% | -62.65% | -54.41% | -66.30% | -35.51% | - |
| Return on Capital Employed (ROCE) | 30.30% | 30.30% | 17.20% | 30.50% | 25.10% | 35.10% |
| Earnings Yield | -111.54% | -61.82% | -4.43% | -6.60% | -0.84% | -1.66% |
| FCF Yield | -109.03% | -60.43% | -1.81% | -4.43% | -0.25% | -0.05% |
| Buyback Yield / Dilution | -35.73% | -35.73% | 82.93% | -188.25% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.